Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation

Weiqiang Chen; Suan‐Sin Foo; Ali Zaid; Terk‐Shin Teng; Lara J. Herrero; Stefan Wolf; Kothila Tharmarajah; Luan D. Vu; Caryn van Vreden; Adam Taylor; Joseph R. Freitas; Rachel Li; Trent M. Woodruff; Richard D. Gordon; David M. Ojcius; Helder I. Nakaya; Thirumala‐Devi Kanneganti; Luke O'neill; Avril A. B. Robertson; Nicholas J. C. King; Andreas Suhrbier; Matthew A. Cooper; Lisa F. P. Ng; Suresh Mahalingam

doi:10.1038/s41564-017-0015-4

Related publications

Article2012

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

Haitao Wen, Jenny P.‐Y. Ting, Luke O'neill

Nature Immunology

Article2012

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

Haitao Wen, Jenny P.‐Y. Ting, Luke O'neill

Carolina Digital Repository (University of North Carolina at Chapel Hill)

Article2016

Evidence against a role for NLRP3-driven inflammation in the db/db mouse model of type 2 diabetes

Hélène L. Kammoun, Tamara L. Allen, Darren C. Henstridge, S. Barre, Rebecca C. Coll, Mark S. Butler, A. A. B. Roberston, Luke O'neill, Andrew Murphy, Matthew A. Cooper, Mark A. Febbraio

ResearchOnline at James Cook University (James Cook University)

Article2016

Evidence against a role for NLRP3-driven inflammation in the db/db mouse model of type 2 diabetes

Hélène L. Kammoun, Tamara L. Allen, Darren C. Henstridge, S. Barre, Rebecca C. Coll, Mark S. Butler, A. A. B. Roberston, Luke O'neill, Andrew Murphy, Matthew A. Cooper, Mark A. Febbraio

ResearchOnline at James Cook University (James Cook University)

Article2013

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes

Rebecca C. Coll, Luke O'neill

PLoS ONE

Specific inhibition of NLRP3 in chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation

Abstract

Discussion(0)

Related publications

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?

Evidence against a role for NLRP3-driven inflammation in the db/db mouse model of type 2 diabetes

Evidence against a role for NLRP3-driven inflammation in the db/db mouse model of type 2 diabetes

Correction: The Cytokine Release Inhibitory Drug CRID3 Targets ASC Oligomerisation in the NLRP3 and AIM2 Inflammasomes